Coegin Pharma AB (NGM:COEGIN)

Coegin Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 18, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	93	110	78	51	97	228
Market Cap Growth	-12.03%	40.73%	55.23%	-47.61%	-57.65%	-
Enterprise Value	85	103	65	44	92	197
Last Close Price	3.73	4.44	3.85	5.38	13.46	36.01
PS Ratio	1174.60	1398.18	-	-	-	-
PB Ratio	19.56	23.29	3.11	7.49	4.59	11.35
P/TBV Ratio	59.33	70.62	4.09	-	10.46	11.35
EV/Sales Ratio	-	1304.89	-	-	-	-
Net Debt / Equity Ratio	-1.67	-1.67	-0.78	-0.82	-0.18	-1.28
Net Debt / EBITDA Ratio	0.46	0.46	0.97	0.22	0.12	0.94
Asset Turnover	0.00	0.00	-	-	-	-
Quick Ratio	0.99	0.99	11.70	0.71	0.84	2.95
Current Ratio	1.16	1.16	11.71	0.72	0.85	2.96
Return on Equity (ROE)	-136.64%	-136.64%	-148.58%	-201.53%	-171.54%	-147.59%
Return on Assets (ROA)	-63.31%	-63.31%	-68.67%	-77.82%	-72.78%	-68.67%
Return on Capital Employed (ROCE)	-431.20%	-431.20%	-92.40%	-412.00%	-165.10%	-135.40%
Earnings Yield	-22.09%	-18.56%	-30.30%	-55.34%	-36.52%	-11.91%
Buyback Yield / Dilution	-31.30%	-31.30%	-105.53%	-34.42%	-15.36%	-354.98%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.